Trim family and tumor

Abstract

Yang Qingmei, Xu Zumin, Guan Chengnong. Trim family and tumor[J]. Journal of International Oncology, 2015, 42(6): 442-444.

［1］ Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment［J］. Nat Med, 2014, 20(11): 1242-1253. ［2］ Micale L, Chaignat E, Fusco C, et al. The tripartite motif: structure and function［J］. Adv Exp Med Biol, 2012, 770: 11-25. ［3］ Ozato K, Shin DM, Chang TH, et al. TRIM family proteins and their emerging roles in innate immunity［J］. Nat Rev Immunol, 2008, 8(11): 849-860. ［4］ Meroni G, DiezRoux G. TRIM/RBCC, a novel class of ′single protein RING finger′ E3 ubiquitin ligases［J］. Bioessays, 2005, 27(11): 1147-1157. ［5］ Khetchoumian K, Teletin M, Tisserand J, et al. Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha［J］. Nat Genet, 2007, 39(12): 1500-1506. ［6］ Chambon M, Orsetti B, Berthe ML, et al. Prognostic significance of TRIM24/TIF-1α gene expression in breast cancer［J］. Am J Pathol, 2011, 178(4): 1461-1469. ［7］ Tsai WW, Wang Z, Yiu TT, et al. TRIM24 links a noncanonical histone signature to breast cancer［J］. Nature, 2010, 468(7326): 927-932. ［8］ Kikuchi M, Okumura F, Tsukiyama T, et al. TRIM24 mediates liganddependent activation of androgen receptor and is repressed by a bromodomaincontaining protein, BRD7, in prostate cancer cells［J］. Biochim Biophys Acta, 2009, 1793(12): 1828-1836. ［9］ Ryu YS, Lee Y, Lee KW, et al. TRIM32 protein sensitizes cells to tumor necrosis factor (TNFα)induced apoptosis via its RING domaindependent E3 ligase activity against Xlinked inhibitor of apoptosis (XIAP)［J］. J Biol Chem, 2011, 286(29): 25729-25738. ［10］ Horn EJ, Albor A, Liu Y, et al. RING protein Trim32 associated with skin carcinogenesis has antiapoptotic and E3ubiquitin ligase properties［J］. Carcinogenesis, 2004, 25(2): 157-167. ［11］ Kano S, Miyajima N, Fukuda S, et al. Tripartite motif protein 32 facilitates cell growth and migration via degradation of Ablinteractor 2［J］. Cancer Res, 2008, 68(14): 5572-5580. ［12］ Liu J, Zhang C, Wang XL, et al. E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis［J］. Cell Death Differ, 2014, 21(11): 1792-1804. ［13］ Fitzgerald S, Sheehan KM, O′Grady A, et al. Relationship between epithelial and stromal TRIM28 expression predicts survival in colorectal cancer patients［J］. J Gastroenterol Hepatol, 2013, 28(6): 967-974. ［14］ Chen L, Chen DT, Kurtyka C, et al. Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions［J］. J Biol Chem, 2012, 287(48): 40106-40118. ［15］ Chen L, MunozAntonia T, Cress WD. Trim28 contributes to EMT via regulation of Ecadherin and Ncadherin in lung cancer cell lines［J］. PloS One, 2014, 9(7): e101040. ［16］ Sho T, Tsukiyama, Sato t, et al. TRIM29 negatively regulates p53 via inhibition of Tip60［J］. Biochim Biophys Acta, 2014, 1813(6): 1245-1253. ［17］ Sun H, Dai X, Han B. TRIM29 as a novel biomarker in pancreatic adebocarnoma［J］. Dis Markers, 2014, 2014: 317817. ［18］ Zhou ZY, Yang GY, Zhou J, et al. Significance of TRIM29 and β-catenin expression in nonsmallcell lung cancer［J］. J Chin Med Assoc, 2012, 75(6): 269-274. ［19］ Hawthorn L, Stein L, Panzarella J, et al. Characterization of celltype specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung［J］. Lung Cancer, 2006, 53(2): 129-142. ［20］ Fristrup N, BirkenkampDemtroder K, Reinert T, et al. Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in nonmuscleinvasive bladder cancer［J］. Am J Pathol, 2013, 182(2): 339-349 . ［21］ Santin AD, Zhan F, Bellone S, et al. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy［J］. Int J Cancer, 2004, 112(1): 14-25. ［22］ Katkoori VR, Shanmugam C, Jia X, et al. Prognostic significance and gene expression profiles of p53 mutations in microsatellitestable stage Ⅲ colorectal adenocarcinomas［J］. PLoS One, 2012, 7(1): e30020. ［23］ Zhan F, Hardin J, Kordsmeier B, et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells［J］. Blood, 2002, 99(5): 1745-1757. ［24］ Kosaka Y, Inoue H, Ohmachi T, et al. Tripartite motifcontaining 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer［J］. Ann Surg Oncol, 2007, 14(9): 2543-2549. ［25］ Horio M, Kato T, Mii S, et al. Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer［J］. Cancer Med, 2012, 1(2):218-229. ［26］ Iwakoshi A, Murakumo Y, Kato T, et al. RET finger protein expression is associated with prognosis in lung cancer with epidermal growth factor receptor mutations［J］. Pathol Int, 2012, 62(5): 324-330. ［27］ Tsukamoto H, Kato T, Enomoto A, et al. Expression of Ret finger protein correlates with outcomes in endometrial cancer［J］. Cancer Sci, 2009, 100(10): 1895-1901. ［28］ Tomar D, Sripada L, Prajapati P, et al. Nucleocytoplasmic trafficking of TRIM8, a novel oncogene, is involved in positive regulation of TNF induced NFκB pathway［J］. PLoS One, 2012, 7(11): e48662. ［29］ Caratozzolo MF, Valletti A, Gigante M, et al. TRIM8 antiproliferative action against chemoresistant renal cell carcinoma［J］. Oncotarget, 2014, 5(17): 7446-7457.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments